Showing 1 - 1 results of 1 for search 'Ranjith Kakkattu', query time: 0.01s Refine Results
  1. 1
    Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera in low-tumor-burden follicular lymphoma: the FLINTER study

    Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera in low-tumor-burden follicular lymphoma: the FLINTER study by Narendra Maharaj, Dharma Rao Uppada, Anand Eswaraiah, Ranjith Kakkattu, Pramod Reddy, Volha A. Kalenik, David Belada, Ana Oliveira Ramos, Jin Seok Kim, Yauheni V. Baranau

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: